The Advisory Committee on Immunization Practices has released its updates to the annual immunization schedules for 2023 that includes new sections on COVID-19 and polio vaccine recommendations.
Authors of a new study evaluated the impact of tenofovir disoproxil fumarate on outcomes of more than 1000 individuals with chronic hepatitis B virus infection with cirrhosis.
In a recent review, the U.S. Preventive Services Task Force sought to update and/or reaffirm its 2009 recommendations for the screening of pregnant women for hepatitis B virus.
Initial results of an ongoing trial of patients with chronic hepatitis B and traditional risk factors associated with tenofovir disoproxil fumarate use were recently presented at Digestive Disease Week...
Following an analysis of 533 patients with chronic HBV, researchers believe that they have identified various predictors of the risk for liver fibrosis in this patient population.
New data from a global study of 120 countries has provided updated information regarding the prevalence of hepatitis B virus around the world and the effects of treatment on disease burden.
Previous studies have indicated that some patients with HBV and HCV co-infection treated with direct-acting antivirals may have a higher risk than others for HBV reactivation. Researchers aimed to explore...
To help improve HBV care, the American College of Physicians and Centers for Disease Control and Prevention have developed new best practice guidance for hepatitis B vaccination and screening.
